跳至主導覽
跳至搜尋
跳過主要內容
國立陽明交通大學研發優勢分析平台 首頁
English
中文
首頁
人員
單位
研究成果
計畫
獎項
活動
貴重儀器
影響
按專業知識、姓名或所屬機構搜尋
查看斯高帕斯 (Scopus) 概要
楊 逢羿
教授
生物醫學影像暨放射科學系
電話
02-28267281, 02-28267000 ext.5546/5522
電子郵件
fyyang
ym.edu
tw
h-index
h10-index
h5-index
1956
引文
26
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
937
引文
18
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
216
引文
7
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
2003
2024
每年研究成果
概覽
指紋
網路
研究成果
(81)
類似的個人檔案
(6)
指紋
查看啟用 Feng-Yi Yang 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Keyphrases
Antitumor Effect
9%
Atherosclerotic Plaque
11%
Blood-brain Barrier
28%
Blood-brain Barrier Disruption
74%
Booking Limits
9%
Brain Injury
16%
Brain Tumor
10%
Brain-derived Neurotrophic Factor
19%
Computational Efficiency
12%
Dynamic Contrast-enhanced Magnetic Resonance Imaging (DCE-MRI)
11%
Evans Blue
41%
Focused Ultrasound
91%
Functional Change
13%
Glioblastoma multiforme
17%
Glioma
17%
Good Enough
15%
Good Enough Solution
15%
High-intensity Focused Ultrasound
10%
Lipopolysaccharide
10%
Lipopolysaccharide-induced
18%
Low-intensity Pulsed Ultrasound (LIPUS)
100%
Magnetic Resonance Imaging
11%
Memory Impairment
9%
Microbubbles
22%
Mouse Model
9%
Neuroinflammation
16%
Neuroprotective Effect
15%
Neurotrophic Factors
16%
Optimization Approach
9%
Ordinal Optimization
20%
Peak Systolic Velocity
10%
Pegylated Liposomal Doxorubicin
11%
Pharmacokinetic Analysis
11%
Pharmacokinetics
11%
Protective Effect
12%
Pulsed Focused Ultrasound
10%
Pulsed High-intensity Focused Ultrasound
26%
Quality Efficiency
10%
Rat Model
28%
Solution Quality
12%
Solution Space
13%
Specific Peptide
11%
Transcranial Focused Ultrasound (tFUS)
18%
Transcranial Ultrasound Stimulation
22%
Traumatic Brain Injury
12%
Tumor
33%
Ultrasound
31%
Ultrasound Contrast Agents
35%
Ultrasound Exposure
16%
Ultrasound Treatment
16%
Pharmacology, Toxicology and Pharmaceutical Science
Binding Protein
5%
Blood-Brain Barrier
70%
Brain Derived Neurotrophic Factor
17%
Brain Disease
7%
Brain Tumor
15%
Chemotherapy
11%
Chitosan
7%
Contrast Medium
5%
Demyelination
5%
Doxorubicin
11%
Echo Contrast Medium
25%
Evans Blue
29%
Extravasation
15%
Fluorine 18
6%
Glioblastoma
19%
Inflammation
14%
Injury
6%
Lipopolysaccharide
23%
Lipopolysaccharide-Induced Neuroinflammation
6%
Liposome
7%
Malignant Neoplasm
6%
Memory Disorder
9%
Mouse
23%
Mouse Model
10%
Neoplasm
45%
Nervous System Inflammation
16%
Neuroprotection
6%
Neuroprotective Agent
17%
Neurotrophic Factor
17%
Oxidopamine
5%
Parkinson's Disease
7%
Pharmacokinetics
19%
Phosphotransferase
5%
Rat Model
25%
Targeted Drug Delivery
5%
Tight Junction Protein
6%
Toll Like Receptor 4
5%
Traumatic Brain Injury
12%
Tropomyosin
5%
Tumor Growth
7%
Tumor Model
6%
Western Blot
7%
Neuroscience
Alzheimer's Disease
6%
Anti-Inflammatory
5%
Astrocyte
8%
Blood Brain Barrier
85%
Brain Injury
13%
Brain Tumor
17%
Brain-Derived Neurotrophic Factor
30%
Cognitive Disorders
5%
Contrast Medium
31%
Cyclic Adenosine Monophosphate
5%
Dementia Praecox
7%
Doxorubicin
11%
Electrical Brain Stimulation
5%
Encephalopathy
5%
Fluorine-18
7%
Glioblastoma Multiforme
8%
Hippocampus
8%
In Vivo
12%
Kinase
5%
Lipopolysaccharide
19%
Magnetic Resonance Imaging
9%
Magnetic Resonance Imaging
7%
Memory Disorder
12%
Microdialysis
7%
Microglia
8%
Multiple Sclerosis
7%
Neuromodulation
6%
Neuroprotection
6%
Neuroprotective Agent
24%
Neurotrauma
12%
Neurotrophic Factor
24%
Oxidopamine
6%
Parkinson's Disease
7%
Pharmacokinetics
20%
Prefrontal Cortex
5%
Protein Binding
5%
Protein Expression
12%
Remyelinization
7%
Response Element
5%
Single-Photon Emission Computed Tomography
6%
Staining Technique
11%
Substantia Nigra Pars Compacta
5%
Tight Junction Protein
5%
TLR 4
5%
Traumatic Brain Injury
12%
Tropomyosin
5%
Western Blot
11%
